sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Belgium and Netherlands Advance Wound Care Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Belgium and Netherlands Advance Wound Care Market Analysis, Companies Profiles,...

Home / Categories / Healthcare
Belgium and Netherlands Advance Wound Care Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
Belgium and Netherlands Advance Wound...
Report Code
RO1/110/1418

Publish Date
01/Oct/2017

Pages
150
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
In this region, Belgium advanced wound care market is projected to reach USD 28.0 million by 2024 from USD 22.6 million in 2016, at a CAGR of 2.8% in the forecast period 2017 to 2024. Netherlands advanced wound care market is projected to reach USD 167.9 million by 2024 from USD 135.4 million in 2016, at a CAGR of 2.8% in the forecast period 2017 to 2024.
Some of the major players operating in this market are
Acelity L.P. INC,
Smith and Nephew,
Molnlycke, Convatec INC.,
3M,
Baxter,
Coloplast,
Ethicon INC.,
Paul Hartmann Limited

The Belgium and Netherlands advance wound care market is segmented on the basis of type, wound type, end-user, distribution channel, and geography. The Belgium and Netherlands advance wound care market is segmented into three types, such as dressing, therapy devices and biologics
Dressing is further segmented into foam dressings, hydrogels, film dressings, alginates, wound contact layer, and super absorbent dressing. Also, biologics market is further segmented into synthetic skin grafts, growth factors, allografts, and xenografts.

The therapy devices are further segmented into negative pressure wound therapy, pressure relief devices (PRD), wound debridement devices, hyperbaric oxygen chambers, and physical therapies.
The growth factors are further divided into platelet-derived growth factor (PDGF), platelet rich plasma (PRP), epidermal growth factor (EGF), basic fibroblast growth factor (BFGF), granulocyte colony stimulating factor (G-CSF), Talactoferrin ALFA, thrombin peptide (TP508), and keratinocyte growth factor (KGF).

The negative pressure wound therapy (NPWT) is further classified into standalone NPWT devices, portable NPWT devices, and disposable NPWT devices. The pressure relief devices (PRD) are further classified into mattress and bed.
The hyperbaric oxygen chambers are further classified into monoplace, multiplace, and topical. The wound debridement devices are further classified into hydrosurgical, ultrasound, mechanical, and others. The physical therapies are further classified into laser therapy, electrical stimulation, external shock wave therapies (ESWT), and saline mist therapy.
On the basis of wound type, the Belgium and Netherlands advance wound care market is segmented into surgical wound, diabetic ulcers, burns, pressure ulcers, venous ulcers and others.

On the basis of end users, the Belgium and Netherlands advance wound care marketis segmented into hospitals, wound care centers, ambulatory centers, home healthcare, clinics and community healthcare.
On the basis of distribution channel, the Belgium and Netherlands advance wound care marketis segmented into direct tenders and retailers.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com